Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.
| Industry | Pharmaceutical Preparations |
| Employees | 2 |
| Headquarters | CAMBERWELL, VICTORIA, C3 |
| Incorporated in | DE |
| Listed on | Nasdaq |
| Listed since | Jun 15, 2012 |
| Fiscal year ends | June 30 |
| SEC filer category | Non-accelerated filer<br>Smaller reporting company |
| Website | propanc.com |
| SEC company number (CIK) | 1517681 |
Company description from Polygon.io. Industry, address and filing details from SEC EDGAR.